Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 5th August 2024
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH responds to CMA issues statement
Regulations surrounding prescription medication impacts how veterinary practices can describe options.
The trade association explained how VMPs are regulated.

The National Office for Animal Health (NOAH) has published its response to the Competition and Markets Authority’s (CMA’s) issues statement.

In its letter NOAH explains how veterinary medicinal products (VMPs) are regulated, and the pricing of VMPs is decided across the industry.

Through NOAH’s Code of Practice, as well as Veterinary Medicines Regulations, companies are prohibited from promoting prescription products to the public. As such, NOAH explains that companies may be restricted in the extent they can inform pet owners of their choices, if such choices relate to prescription-only products.

NOAH describes how the animal health industry has no involvement in the pricing of veterinary medicines for the public. While the animal health industry does decide upon the prices which prescribing veterinary practices and wholesalers pay, it does not devise the prices which pet owners then pay.

The trade association explains that many owners may also not understand that prescriptions can be fulfilled in online pharmacies or other veterinary practices. It suggests that greater publicity on this matter may benefit clients.

NOAH also explains how medicine regulation and the involvement of the Veterinary Medicines Directorate (VMD) affects the medicine market.

This includes the lengthy and expensive process of developing an animal medicine, and the four classifications under which veterinary medicines can be sold.

NOAH calls the veterinary medicines sector a ‘comparatively small industry’, in that the case for producing a veterinary medicine is dependent on them being used ahead of human medicines and unauthorised products.

Dawn Howard, NOAH chief executive, said: “We appreciate the CMA’s attention to the veterinary sector and the opportunity to provide our perspective. The veterinary medicines industry and veterinarians are essential in safeguarding animal health and welfare, and it is crucial that any regulatory changes consider the unique aspects of how our sector and veterinary practices operate.

“NOAH is committed to working with the CMA to ensure that the needs of pet owners, as well as the professional and economic realities of the animal health industry and veterinary practices, are met.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Webinar to explore history of KC breed registers

News Story 1
 A free webinar exploring the development of the Kennel Club's registration system and the evolution of closed breed registers has been announced.

Hosted by Dr Alison Skipper, veterinary and research advisor at the Kennel Club, the webinar will delve into the development of the registry and how the changing landscape of scientific knowledge has shaped breeding practices. It will also look at what this means for the future of pedigree dogs.

The session will culminate with a look at The Kennel Club's ongoing and future engagement in this area, with a chance for attendees to put forward their thoughts and questions for discussion.

This event takes place on Microsoft Teams on Tuesday, 10 June at 7pm. To learn more, visit events.teams.microsoft.com  

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.